Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial of the Effectiveness of Adherence Data and Motivational Interviewing to Improve Medication Adherence and Both Glycated Hemoglobin and Cholesterol Control

NCT00754741 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT00754741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00754741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial of the Effectiveness of Adherence Data and Motivational Interviewing to Improve Medication Adherence and Both Glycated Hemoglobin and Cholesterol Control
Lead sponsor
Henry Ford Health System
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2012
Enrollment
1,692 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes